Keywords
ICAM
SPSS
RT-PCR
Abstract
The study was conducted on seventy individuals of both genders who have been exposed to human cytomegalovirus, a common illness in Iraq. Total cases of human cytomegvirus associated with malignant brain tumors were detected by a real time PCR technique.
This resulted in only thirty-six cases of true infection. Of these 24 cases were female, while 12 cases of male infected. The titer to assay the presence of anti- and pro-inflammatories was assessed in sera of all patients by using ELISA kits to evaluate cytokines. This indicated that the pro-inflammatory IL12, after seven days increased (1.67±0.23 pg/ml), while IL4, an anti-inflammatory, decreased to reach (0.39±0.16 pg/ml) (at p<0.05) in the plasm of the experimental patients compared with the control group.
References
1. Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev. 2009;22:76-98.
2. Hummel M, Abecassis MM. A model for reactivation of CMV from latency. J Clin Virol. 2002;25:123-36.
3. MC Guedes MI, Risdahl JM, Wiseman B, Molitor TW. Reactivation of porcine cytomegalovirus through allogeneic stimulation. J Clin Microbiol. 2004;42:1756-8.
4. Muller LV, Klemn A, Weiss M, Schneider M, Sugar-Wiedeck H, Durmus N, et al. Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis. 2006;12:1517-22.
5. Taher C, de Boniface J, Mohammad AA, Religa P, Hartman J, Yaiw KC, et al. High prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes. PLos One. 2013;10:1371-7.
6. Kaveh B. Oncomodulatory mechanism of HCMV in glioma. J Clin Neurosci. 2010;17:819-23.
7. Samanta M, Harkins L, Cobbs CS, Yancey Gillespie G, Bharara S, King PH, et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002;62(12):3347-50.
8. Joki T, Kikuchi T, Akasaki Y, Saitoh S, Abe T, Ohno T. Induction of effective antitumor immunity in a mouse brain tumor model using B7-1(CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12. Int J Cancer. 1999;82:714.
9. Michelucci A, Heurtaux T, Grandbarbe L, Morga E, Heuschling P. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta. J Neuroimmunol. 2009;210:3-12.
10. Howard M, Farrar J, Hilfiker M, Johnson B, Takatsu K, Hamaoka T, Paul WE. Identification of a T cell-derived b cell growth factor distinct from interleukin 2. J Exp Med. 1982;155:914-23
11. Antoine GC, Jean CN, Chahrazed B, Axelle D, Yanne M, Elyanne G. Quantification of Human Cytomegalovirus DNA by Real-Time PCR. J Clin Microbiol. 2001;39(2) 772-5.
12. Iraqi Cancer Registry; 2005
13. Brousset P, Delisle MB, Trémoulet M, Allart S, Labrousse F, Pommepuy I, Uro-Coste E. Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Brit J Cancer. 2005;92:747-50.
14. El-Zein R, Albrecht T, Aldape KD, Bondy ML, Scheurer ME. Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol. 2008;116(1):79-86.
15. Udai PS, Haider SK, Aws RH, Abdulameer K, Dennis DT, Robert LP, et al. Detection of human cytomegalovirus in different histo-pathological types of glioma in Iraqi patients. Hindawi Publishing Corporation. BioMed Res Int. 2015;10.
16. Sampson JH, Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE. Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro-Oncology. 2008;10(1):10-8.
17. Puri KR, Varricchio F, Prayson AR, Joshi BH, Leland P, Asher A. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures. Cancer Res. 2001;61:8058-61.
18. Kranz MD, Webb AG. IL-12 Treatment of Endogenously Arising. J Immunol. 2016;165:7293-9.
19. Kipnis J, Norris T, Cronk CJ, Gadani SP. IL-4 in the brain. J Immunol. 2016;189:4213-9.
20. Puri KR, Varricchio F, Prayson AR, Joshi BH, Leland P, Asher A. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures. Cancer Res. 2001;61:8058-61.
21. Kranz MD, Webb AG. IL-12 Treatment of endogenously arising. J Immunol. 2016;165:7293-9.
22. Kipnis J, Norris T, Cronk CJ, Gadani SP. IL-4 in the brain. J Immunol. 2016;189:4213-9.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
Copyright (c) 2020 Autors